New York State Teachers Retirement System Purchases 457 Shares of Enovis Co. (NYSE:ENOV)

New York State Teachers Retirement System raised its position in shares of Enovis Co. (NYSE:ENOV) by 3.5% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 13,538 shares of the company’s stock after purchasing an additional 457 shares during the quarter. New York State Teachers Retirement System’s holdings in Enovis were worth $594,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also recently made changes to their positions in the company. Confluence Investment Management LLC bought a new position in Enovis in the 4th quarter worth $3,494,000. Chartwell Investment Partners LLC lifted its position in shares of Enovis by 25.6% during the 3rd quarter. Chartwell Investment Partners LLC now owns 201,652 shares of the company’s stock valued at $8,681,000 after buying an additional 41,089 shares in the last quarter. Geode Capital Management LLC grew its stake in shares of Enovis by 9.5% during the 3rd quarter. Geode Capital Management LLC now owns 921,437 shares of the company’s stock valued at $39,678,000 after acquiring an additional 80,165 shares during the period. UMB Bank n.a. increased its holdings in Enovis by 128.2% in the 4th quarter. UMB Bank n.a. now owns 778 shares of the company’s stock worth $34,000 after acquiring an additional 437 shares in the last quarter. Finally, Dynamic Technology Lab Private Ltd bought a new stake in Enovis during the 3rd quarter worth approximately $1,050,000. Hedge funds and other institutional investors own 98.45% of the company’s stock.

Enovis Price Performance

Shares of Enovis stock opened at $43.55 on Tuesday. The company has a market capitalization of $2.48 billion, a price-to-earnings ratio of -19.88 and a beta of 1.94. The company has a quick ratio of 1.12, a current ratio of 2.27 and a debt-to-equity ratio of 0.40. The stock’s 50-day simple moving average is $45.03 and its 200-day simple moving average is $44.38. Enovis Co. has a 52 week low of $38.27 and a 52 week high of $63.96.

Analysts Set New Price Targets

Separately, Needham & Company LLC reiterated a “buy” rating and issued a $65.00 price target on shares of Enovis in a research report on Thursday, November 7th.

About Enovis

Enovis Corporation operates as a medical technology company focus on developing clinically differentiated solutions worldwide. It also manufactures and distributes medical devices which are used for reconstructive surgery, rehabilitation, pain management, and physical therapy. The company operates through Prevention and Recovery, and Reconstructive segments.